| Market Cap | — | |
| Enterprise Value | — | |
| Revenue | £12.95B | +1.3% |
| Gross Profit | £4.93B | +3.5% |
| EBITDA | — | — |
| Net Income | £245.0M | +32.4% |
| Diluted EPS | £0.14 | +39.4% |
| Free Cash Flow | £1.13B | +6.5% |
| DPS (FY2026) | — |
| Trailing yield | — |
| Payout ratio | — |
| Growth streak | — |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20262026-01-31 | — | — | reported |
| FY20252025-01-31 | — | — | reported |
| FY20242024-01-31 | — | — | reported |
| FY20232023-01-31 | — | — | reported |
| FY2022 |
| Ratio | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Trend · 6y | vs own |
|---|---|---|---|---|---|---|---|---|
| ▾Margins | ||||||||
| Gross Margin | 37.05% | 37.43% | 36.72% | 36.80% | 37.26% | 38.08% | 92% | |
| Operating Margin | 7.42% | 8.68% | 5.54% | 4.47% | 3.18% | 3.62% | 25% | |
| NOPAT Margin | 5.81% | 7.26% | 4.27% | 3.25% | 1.92% | 2.35% | 25% | |
| Net Margin | 4.80% | 6.39% | 3.61% | 2.66% | 1.45% | 1.89% | 25% | |
| FCF Margin | — | — | — | — | 8.30% | 8.73% | 75% | |
| FCFF Margin | — | — | — | — | 8.92% | 9.35% | 75% | |
| OCF Margin | 13.37% | 8.94% | 6.28% | 10.18% | 10.18% | 11.07% | 75% | |
| Gross Profitability | 37.27% | 39.95% | 39.62% | 40.13% | 41.62% | 43.25% | 92% | |
| Capex Intensity | — | — | — | — | 1.89% | 2.34% | 75% | |
| ▸Returns on Capital · 6 ratios | ||||||||
| ▸DuPont factors (ROE drivers) · 4 ratios | ||||||||
| ▸Earnings quality · 5 ratios | ||||||||
| ▸Liquidity & coverage · 7 ratios | ||||||||
| ▸Leverage · 8 ratios | ||||||||
| ▸Working capital · 8 ratios | ||||||||
| ▸Capital allocation · 3 ratios | ||||||||
| ▸Other · 1 ratios | ||||||||
The five drivers multiply to 4.0% vs reported ROE 3.9%. High ROE from margin and turnover is earned; from the equity multiplier it is borrowed.
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Revenue | £12.34B | £13.18B | £13.06B | £12.98B | £12.78B | £12.95B |
| YoY % | +6.8% | -0.9% | -0.6% | -1.5% | +1.3% | |
| Cost of Revenue | £7.77B | £8.25B | £8.26B | £8.20B | £8.02B | £8.02B |
| YoY % | +6.2% | +0.2% | -0.7% | -2.2% | -0.1% | |
| Gross Profit | £4.57B | £4.93B | £4.79B | £4.78B | £4.76B | £4.93B |
| YoY % | +7.9% | -2.8% | -0.4% | -0.3% | +3.5% | |
| SG&A Expense | £815.0M | £823.0M | £880.0M | £990.0M | £1.11B | £1.16B |
| YoY % | +1.0% | +6.9% | +12.5% | +12.6% | +3.6% | |
| Operating Income | £916.0M | £1.14B | £723.0M | £580.0M | £407.0M | £469.0M |
| YoY % | +24.9% | -36.8% | -19.8% | -29.8% | +15.2% | |
| Interest Expense | £180.0M | £148.0M | £129.0M | £133.0M | £132.0M | £124.0M |
| YoY % | -17.8% | -12.8% | +3.1% | -0.8% | -6.1% | |
| Interest & Investment Income | £20.0M | £11.0M | £17.0M | £28.0M | £32.0M | £33.0M |
| YoY % | -45.0% | +54.5% | +64.7% | +14.3% | +3.1% | |
| Equity Method Income | £6.0M | £5.0M | £5.0M | -£1.0M | -£15.0M | -£28.0M |
| YoY % | -16.7% | 0.0% | ||||
| Pretax Income | £756.0M | £1.01B | £611.0M | £475.0M | £307.0M | £378.0M |
| YoY % | +33.2% | -39.3% | -22.3% | -35.4% | +23.1% | |
| Income Tax | £164.0M | £164.0M | £140.0M | £130.0M | £122.0M | £133.0M |
| YoY % | 0.0% | -14.6% | -7.1% | -6.2% | +9.0% | |
| Net Income (incl. NCI) | £592.0M | £843.0M | £471.0M | £345.0M | £185.0M | £245.0M |
| YoY % | +42.4% | -44.1% | -26.8% | -46.4% | +32.4% | |
| EPS (Basic) | £0.28 | £0.40 | £0.24 | £0.18 | £0.10 | £0.14 |
| YoY % | +43.4% | -40.9% | -23.5% | -44.5% | +38.6% | |
| EPS (Diluted) | £0.28 | £0.40 | £0.23 | £0.18 | £0.10 | £0.14 |
| YoY % | +42.7% | -41.0% | -23.4% | -45.0% | +39.4% |
Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
| — |
| — |
| reported |
